Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1374196 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Small molecule inhibitors of adipocyte fatty-acid binding protein (A-FABP) have gained renewed interest following the recent publication of pharmacologically beneficial effects of such inhibitors. Despite the potential utility of selective A-FABP inhibitors within the fields of metabolic disease, inflammation and atherosclerosis, there are few examples of useful A-FABP inhibitors in the public domain. Herein, we describe the optimization of N-benzyl-tetrahydrocarbazole derivatives through the use of co-crystal structure guided medicinal chemistry efforts. This led to the identification of a potent and selective class of A-FABP inhibitors as illustrated by N-benzyl-hexahydrocyclohepta[b]indole 30.
Graphical abstractA novel class of hexahydrocyclohepta[b]indole-based A-FABP inhibitors have been synthesized and evaluated. The potency, selectivity profile, and structure–activity relationship trends of this class of compounds are discussed.Figure optionsDownload full-size imageDownload as PowerPoint slide